Makana Therapeutics

Makana Therapeutics will be exclusively focused on solving the organ shortage crisis. We are focusing on and commercializing a pipeline of transplantable cells, tissues, and organs for human patient use. Xenotransplantation is the process of transplanting organs or tissues between members of different species into humans, thus addressing the crisis of organ shortage we are facing today. Thus far, the xenotransplantation industry has been limited to cells and tissues and has yet to realize the production of organs suitable for donation

Makana therapeutics operates in the Biotechnology industry.

Makana therapeutics's revenue is 11m - 100m

Makana therapeutics has 11 - 50 employees.